According to BBC Technology, scientists have developed a molecular thermal energy storage technology inspired by sunburn mechanisms. These molecules can capture and store heat, releasing it on demand, offering a potential clean decarbonization solution for building heating and industrial processes.

If commercialized, this technology could replace traditional fossil fuel heating methods, with significant implications for carbon emission reduction.

Source: BBC Technology

On May 1, 2026, the BBC reported that a new study suggests psilocybin, the active compound found in magic mushrooms, could be an effective treatment to help smokers quit.

More than 8 million people worldwide die from tobacco-related diseases each year, making smoking cessation one of the most challenging public health goals. Current quit-smoking methods, including nicotine replacement therapy and prescription medications, still have limited long-term success rates.

Research indicates that in controlled medical settings, psilocybin-assisted therapy can help smokers re-examine their relationship with nicotine. Scientists found that participants who received psilocybin treatment showed significantly higher quit rates sustained over months following the therapy.

Psilocybin is a hallucinogenic compound naturally found in certain mushroom species. In recent years, scientists have developed a strong interest in its applications in mental health, with previous studies suggesting potential in treating depression, post-traumatic stress disorder, and addiction.

Researchers emphasized that psilocybin treatment must be conducted under strict supervision of qualified medical professionals, as self-administration of magic mushrooms carries serious health risks. As regulatory frameworks around psychedelic medicine gradually evolve in various countries, more clinical trials are underway.

The medical community views this research as opening new directions for developing novel smoking cessation therapies, though larger-scale clinical trials are still needed to confirm long-term effectiveness and safety.

Source: BBC

On April 30, 2026, the BBC reported a breakthrough medical AI application: artificial intelligence systems are helping doctors detect “hidden sperm” in semen samples from men previously diagnosed with azoospermia — a condition characterized by the complete absence of sperm. This technological breakthrough is bringing new hope to millions of men who were previously told they could not father children biologically.

How the Technology Works

Traditional semen analysis relies on laboratory technicians manually examining samples under a microscope to detect the presence of sperm. However, when sperm counts are extremely low, even experienced technicians may miss them. AI systems, using deep learning algorithms, can perform more systematic and precise analyses of semen samples, identifying trace amounts of sperm that the human eye might overlook.

According to the BBC, this AI system has been trained on hundreds of thousands of semen samples and can detect extremely low sperm concentrations with far greater precision than human examination. In some cases, the AI has successfully found viable sperm suitable for in vitro fertilization (IVF) in samples that humans had diagnosed as containing “zero sperm.”

Clinical Significance

For men diagnosed with azoospermia, this discovery carries profound significance. Traditionally, azoospermia meant that sperm could not be obtained through conventional means for assisted reproduction. However, AI technology applications suggest that some men diagnosed with azoospermia actually have trace amounts of sperm that could be used for fertilization through intracytoplasmic sperm injection (ICSI) techniques.

Reproductive medicine experts note that approximately 1% to 2% of men worldwide are affected by azoospermia, and a significant portion of these may have “pseudo-azoospermia” — meaning trace sperm exists but went undetected. The adoption of AI technology could enable these patients to regain fertility.

Real-World Applications

The report noted that several reproductive medicine centers have already begun deploying this AI-assisted detection system. In early applications, the system successfully found usable sperm in approximately 15% to 20% of samples diagnosed as azoospermic — a discovery rate far exceeding that of traditional detection methods.

Ethical Considerations

While the technology brings enormous medical value, it has also sparked ethical discussion. Some experts caution that the accuracy and reliability of AI diagnosis still need to be validated through larger-scale clinical trials. Additionally, how to distribute this new technology equitably in resource-limited settings remains a concern.

The reproductive medicine community broadly views AI-assisted sperm detection as representing an important advancement in fertility medicine, with the potential to become standard equipment in fertility centers worldwide within the next few years.

Source: BBC